inserm umr 1149 (Inserm Transfert)
86
Structured Review
Inserm Transfert
inserm umr 1149
Inserm Umr 1149, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserm+umrs+1149/1149+inserm+umr/pm42314930-15-16-16
Average 86 stars, based on 1 article reviews
Inserm Umr 1149, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserm+umrs+1149/1149+inserm+umr/pm42314930-15-16-16
Average 86 stars, based on 1 article reviews
inserm umr 1149 - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: EMBRN-COST International Mast cell and Basophil Meeting, satellite pof ICI2013. Article Snippet: At the end of August 2013, the SIICA and the EMBRN, i.e. the talian Society of Immunology and the European Mast cell and asophil Network, put together their forces and organized a joint eeting at the “Palazzo della Regione” in Udine, a splendid Italan town in the North East of Italy.. The meeting was attended by 20 scientists who came from different parts of the world, and was osted by the EU COST Action BM1007 “Mast cells and basophils” nd was one of the Satellite meetings of the 15th International ongress of Immunology, which was held a few days before in ilan.. The organizing committee was smart enough to book three onderful sunny, windy, but not sizzling days as a prerequisite for ome of planned activity and to enjoy the meeting, but also the ity. Article Title: Cell metabolism-based therapy for liver fibrosis, repair and hepatocellular carcinoma Article Snippet: Progression of chronic liver injury to fibrosis, abnormal liver regeneration, and HCC is driven by a dysregulated dialog between epithelial cells and their microenvironment, in particular immune, fibroblasts, and endothelial cells.. There is currently no antifibrogenic therapy, and drug treatment of HCC is limited to tyrosine kinase inhibitors and immunotherapy targeting the tumor microenvironment.. Metabolic reprogramming of epithelial and nonparenchymal cells is critical at each stage of disease progression, suggesting that targeting specific metabolic pathways could constitute an interesting therapeutic approach. Article Title: Kidney transplantation in adult candidates with obesity: guidelines by the Association Française d'Urologie and Société Francophone de Transplantation. Article Snippet: Marc-Olivier Timsit Judith Aron-Wisnewsky Thomas Bessede Diana Kassab Lucile Amrouche Lucas Bento Thibaud Bertrand Sophie Caillard-Ohlmann Laurent Genser Anne-Elisabeth Heng Anne-Sophie Joly Emilie Montastier Pauline Moreau Myriam Pastural Florence Poinard Thomas Prudhomme Emilien Seizilles de Mazancourt Brigitte Thevenin-Lemoine Tigran Poghosyan Sarah Drouin Thibaut Culty, for the AFU working group CMC:Article Title: Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study. Article Snippet: journal homepage: ht tp: / /www.elsevier .com/locate/c lnu 56 57 58 59 60 61 62 63 64 Original article 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study F. Joly a, b, , D. Seguy , A. Nuzzo , C. Chambrier , P. Beau , F. Poullenot , R. Thibault , L. Armengol Debeir , S. Layec , V. Boehm , J. Lallemand , D. Quilliot , S.M.. Schneider l |